In our studies of FLT3-ITD–expressing cell lines and AML patient blasts, Pim inhibitors alone did not downregulate c-Myc, but Pim and FLT3 inhibitor cotreatment downregulated c-Myc more markedly and more rapidly than FLT3 inhibitor alone, likely contributing to enhanced apoptosis induction by combination therapy, demonstrated previously (9–12) and here. Here, MYC is linked to acute myeloid leukemia.